Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05950334
Title FT522 With Rituximab in Relapsed/Refractory B-Cell Lymphoma (FT522-101)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fate Therapeutics
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.